Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Index by author

May 01, 1994; Volume 269,Issue 2
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Agneter, E

    1. You have access
      Behavior of mesocortical dopamine terminals during single and repetitive stimulation: comparison with nigrostriatal neurons.
      E Agneter, I S Hoffmann, E A Singer and L X Cubeddu
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 470-476;
  2. Aguayo, L G

    1. You have access
      Dopamine inhibits a sustained calcium current through activation of alpha adrenergic receptors and a GTP-binding protein in adult rat sympathetic neurons.
      L G Aguayo and J Grossie
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 503-508;
  3. Akai, T

    1. You have access
      Chronic pharmacological activities of the novel anxiolytic beta-carboline abecarnil in rats.
      M Ozawa, K Sugimachi, Y Nakada-Kometani, T Akai and M Yamaguchi
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 457-462;
  4. Akuzawa, S

    1. You have access
      Pharmacological profile of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo- 5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo.
      A Nishida, K Miyata, R Tsutsumi, H Yuki, S Akuzawa, A Kobayashi, T Kamato, H Ito, M Yamano and Y Katuyama
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 725-731;
  5. Alloatti, G

    1. You have access
      Role of platelet-activating factor (PAF) in oxygen radical-induced cardiac dysfunction.
      G Alloatti, G Montrucchio and G Camussi
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 766-771;
  6. Appleby, S D

    1. You have access
      Cardiac electrophysiologic and antiarrhythmic actions of two long-acting spirobenzopyran piperidine class III agents, L-702,958 and L-706,000 [MK-499].
      J J Lynch, A A Wallace, R F Stupienski, E P Baskin, C M Beare, S D Appleby, J J Salata, N K Jurkiewicz, M C Sanguinetti and R B Stein
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 541-554;
  7. Avram, M J

    1. You have access
      A recirculatory pharmacokinetic model describing the circulatory mixing, tissue distribution and elimination of antipyrine in dogs.
      T C Krejcie, T K Henthorn, C A Shanks and M J Avram
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 609-616;

B

  1. Baskin, E P

    1. You have access
      Cardiac electrophysiologic and antiarrhythmic actions of two long-acting spirobenzopyran piperidine class III agents, L-702,958 and L-706,000 [MK-499].
      J J Lynch, A A Wallace, R F Stupienski, E P Baskin, C M Beare, S D Appleby, J J Salata, N K Jurkiewicz, M C Sanguinetti and R B Stein
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 541-554;
  2. Battaglia, G

    1. You have access
      Delayed decreases in brain 5-hydroxytryptamine2A/2C receptor density and function in male rat progeny following prenatal fluoxetine.
      T M Cabrera and G Battaglia
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 637-645;
  3. Beare, C M

    1. You have access
      Cardiac electrophysiologic and antiarrhythmic actions of two long-acting spirobenzopyran piperidine class III agents, L-702,958 and L-706,000 [MK-499].
      J J Lynch, A A Wallace, R F Stupienski, E P Baskin, C M Beare, S D Appleby, J J Salata, N K Jurkiewicz, M C Sanguinetti and R B Stein
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 541-554;
  4. Besch, H R

    1. You have access
      Dual effect of suramin on calcium fluxes across sarcoplasmic reticulum vesicle membranes.
      J T Emmick, S Kwon, K R Bidasee, K T Besch and H R Besch
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 717-724;
  5. Besch, K T

    1. You have access
      Dual effect of suramin on calcium fluxes across sarcoplasmic reticulum vesicle membranes.
      J T Emmick, S Kwon, K R Bidasee, K T Besch and H R Besch
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 717-724;
  6. Bidasee, K R

    1. You have access
      Dual effect of suramin on calcium fluxes across sarcoplasmic reticulum vesicle membranes.
      J T Emmick, S Kwon, K R Bidasee, K T Besch and H R Besch
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 717-724;
  7. Böhm, M

    1. You have access
      Inotropic effect of the cardioprotective agent 2,3-butanedione monoxime in failing and nonfailing human myocardium.
      R H Schwinger, M Böhm, A Koch, I Morano, J C Rüegg and E Erdmann
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 778-786;
  8. Bouzom, F

    1. You have access
      S 12340: a potent inhibitor of the oxidative modification of low-density lipoprotein in vitro and ex vivo in WHHL rabbits.
      C Breugnot, S Privat, C Guillonneau, G Regnier, F Bouzom, J P Vilaine and A Lenaers
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 515-520;
  9. Bowden, G

    1. You have access
      SNF9007: a novel analgesic that acts simultaneously at delta 1, delta 2 and mu opioid receptors.
      C L Williams, G C Rosenfeld, N Dafny, S N Fang, V J Hruby, G Bowden, C A Cullinan and T F Burks
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 750-755;
  10. Branch, C A

    1. You have access
      Causes of differential cardiovascular sensitivity to cocaine. I: Studies in conscious rats.
      C A Branch and M M Knuepfer
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 674-683;
  11. Breneisen, J R

    1. You have access
      Antagonism of nitrous oxide antinociception in the rat hot plate test by site-specific mu and epsilon opioid receptor blockade.
      B L Hodges, M J Gagnon, T R Gillespie, J R Breneisen, D F O'Leary, S Hara and R M Quock
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 596-600;
  12. Breugnot, C

    1. You have access
      S 12340: a potent inhibitor of the oxidative modification of low-density lipoprotein in vitro and ex vivo in WHHL rabbits.
      C Breugnot, S Privat, C Guillonneau, G Regnier, F Bouzom, J P Vilaine and A Lenaers
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 515-520;
  13. Buckpitt, A

    1. You have access
      Covalent interactions of reactive naphthalene metabolites with proteins.
      M Cho, C Chichester, D Morin, C Plopper and A Buckpitt
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 881-889;
  14. Buckpitt, A R

    1. You have access
      Elevated susceptibility to 4-ipomeanol cytotoxicity in immature Clara cells of neonatal rabbits.
      C G Plopper, A J Weir, S J Nishio, A Chang, M Voit, R M Philpot and A R Buckpitt
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 867-880;
  15. Burka, L T

    1. You have access
      Investigation of methacrylonitrile metabolism and the metabolic basis for the differences in its toxicity in rats and mice.
      B I Ghanayem, I M Sanchez and L T Burka
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 581-588;
  16. Burks, T F

    1. You have access
      SNF9007: a novel analgesic that acts simultaneously at delta 1, delta 2 and mu opioid receptors.
      C L Williams, G C Rosenfeld, N Dafny, S N Fang, V J Hruby, G Bowden, C A Cullinan and T F Burks
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 750-755;

C

  1. Cabrera, T M

    1. You have access
      Delayed decreases in brain 5-hydroxytryptamine2A/2C receptor density and function in male rat progeny following prenatal fluoxetine.
      T M Cabrera and G Battaglia
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 637-645;
  2. Camussi, G

    1. You have access
      Role of platelet-activating factor (PAF) in oxygen radical-induced cardiac dysfunction.
      G Alloatti, G Montrucchio and G Camussi
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 766-771;
  3. Caron, M G

    1. You have access
      Withdrawal from continuous or intermittent cocaine administration: changes in D2 receptor function.
      G R King, E H Ellinwood, C Silvia, C M Joyner, Z Xue, M G Caron and T H Lee
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 743-749;
  4. Carr, D J

    1. You have access
      Naltrexone antagonizes the analgesic and immunosuppressive effects of morphine in mice.
      D J Carr, L R Gerak and C P France
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 693-698;
  5. Carter, A J

    1. You have access
      Many agents that antagonize the NMDA receptor-channel complex in vivo also cause disturbances of motor coordination.
      A J Carter
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 573-580;
  6. Chang, A

    1. You have access
      Elevated susceptibility to 4-ipomeanol cytotoxicity in immature Clara cells of neonatal rabbits.
      C G Plopper, A J Weir, S J Nishio, A Chang, M Voit, R M Philpot and A R Buckpitt
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 867-880;
  7. Chen, J

    1. You have access
      Neuroprotective effects of a use-dependent blocker of voltage-dependent sodium channels, BW619C89, in rat middle cerebral artery occlusion.
      S H Graham, J Chen, J Lan, M J Leach and R P Simon
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 854-859;
  8. Chen, Q M

    1. You have access
      Chlorotyrosine exerts renal effects and antagonizes renal and gastric responses to atrial natriuretic peptide.
      Q M Chen, D D Smyth, J K McKenzie, G B Glavin, J G Gu, J D Geiger and F S LaBella
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 709-716;
  9. Chichester, C

    1. You have access
      Covalent interactions of reactive naphthalene metabolites with proteins.
      M Cho, C Chichester, D Morin, C Plopper and A Buckpitt
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 881-889;
  10. Cho, M

    1. You have access
      Covalent interactions of reactive naphthalene metabolites with proteins.
      M Cho, C Chichester, D Morin, C Plopper and A Buckpitt
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 881-889;
  11. Clarke, G A

    1. You have access
      Stimulatory and inhibitory action of nitric oxide donor agents vs. nitrovasodilators on reactive oxygen production by isolated polymorphonuclear leukocytes.
      G M Pieper, G A Clarke and G J Gross
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 451-456;
  12. Combre, A

    1. You have access
      Malondialdehyde dosimetry in laser-irradiated tissues sensitized by hematoporphyrin derivative.
      C Perret, M T Foultier, V Vonarx-Coinsman, O Quancard, A Combre and T Patrice
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 787-791;
  13. Cordier, J

    1. You have access
      Muscarinic cholinergic agonists stimulate arachidonic acid release from mouse striatal neurons in primary culture.
      M Tencé, J Cordier, J Premont and J Glowinski
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 646-653;
  14. Cubeddu, L X

    1. You have access
      Behavior of mesocortical dopamine terminals during single and repetitive stimulation: comparison with nigrostriatal neurons.
      E Agneter, I S Hoffmann, E A Singer and L X Cubeddu
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 470-476;
  15. Cullinan, C A

    1. You have access
      SNF9007: a novel analgesic that acts simultaneously at delta 1, delta 2 and mu opioid receptors.
      C L Williams, G C Rosenfeld, N Dafny, S N Fang, V J Hruby, G Bowden, C A Cullinan and T F Burks
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 750-755;

D

  1. D'Alonzo, A J

    1. You have access
      The cardioprotective and electrophysiological effects of cromakalim are attenuated by meclofenamate through a cyclooxygenase-independent mechanism.
      G J Grover, A J D'Alonzo, P G Sleph, S Dzwonczyk, T A Hess and R B Darbenzio
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 536-540;
  2. Dafny, N

    1. You have access
      SNF9007: a novel analgesic that acts simultaneously at delta 1, delta 2 and mu opioid receptors.
      C L Williams, G C Rosenfeld, N Dafny, S N Fang, V J Hruby, G Bowden, C A Cullinan and T F Burks
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 750-755;
  3. Danhof, M

    1. You have access
      Characterization of the pharmacodynamics of several antiepileptic drugs in a direct cortical stimulation model of anticonvulsant effect in the rat.
      A Hoogerkamp, P W Vis, M Danhof and R A Voskuyl
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 521-528;
  4. Darbenzio, R B

    1. You have access
      The cardioprotective and electrophysiological effects of cromakalim are attenuated by meclofenamate through a cyclooxygenase-independent mechanism.
      G J Grover, A J D'Alonzo, P G Sleph, S Dzwonczyk, T A Hess and R B Darbenzio
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 536-540;
  5. David, C

    1. You have access
      Polysubstrates: substances that interact with renal contraluminal PAH, sulfate, and NMeN transport: sulfamoyl-, sulfonylurea-, thiazide- and benzeneamino-carboxylate (nicotinate) compounds.
      K J Ullrich, G Fritzsch, G Rumrich and C David
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 684-692;
  6. Davis, T P

    1. You have access
      Acute administration of neuroleptics decreases neurotensin metabolism on intact, regional rat brain slices.
      C S Konkoy, S M Waters and T P Davis
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 555-563;
  7. Derewlany, L O

    1. You have access
      Arylamine N-acetyltransferase activity of the human placenta.
      L O Derewlany, B Knie and G Koren
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 756-760;
    2. You have access
      Human placental transfer and metabolism of p-aminobenzoic acid.
      L O Derewlany, B Knie and G Koren
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 761-765;
  8. Dorsa, D M

    1. You have access
      Induction of neurotensin and c-fos mRNA in distinct subregions of rat neostriatum after acute methamphetamine: comparison with acute haloperidol effects.
      K M Merchant, G R Hanson and D M Dorsa
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 806-812;
  9. Duff, H

    1. You have access
      Interaction of drug metabolites with the class I antiarrhythmic drug receptor on rat cardiac myocytes.
      R Sheldon, E Thakore, L Wilson and H Duff
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 477-481;
  10. Dzwonczyk, S

    1. You have access
      The cardioprotective and electrophysiological effects of cromakalim are attenuated by meclofenamate through a cyclooxygenase-independent mechanism.
      G J Grover, A J D'Alonzo, P G Sleph, S Dzwonczyk, T A Hess and R B Darbenzio
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 536-540;

E

  1. Egi, Y

    1. You have access
      The effects of NG-nitro-L-arginine, a nitric oxide synthase inhibitor, on norepinephrine overflow and antidiuresis induced by stimulation of renal nerves in anesthetized dogs.
      Y Egi, Y Matsumura, S Murata, T Umekawa, K Hisaki, M Takaoka and S Morimoto
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 529-535;
  2. Ellenberger, E A

    1. You have access
      Inhibitors of nitric oxide synthesis antagonize nitrous oxide antinociception in mice and rats.
      C E McDonald, M J Gagnon, E A Ellenberger, B L Hodges, J K Ream, S A Tousman and R M Quock
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 601-608;
  3. Ellinwood, E H

    1. You have access
      Withdrawal from continuous or intermittent cocaine administration: changes in D2 receptor function.
      G R King, E H Ellinwood, C Silvia, C M Joyner, Z Xue, M G Caron and T H Lee
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 743-749;
  4. Emmick, J T

    1. You have access
      Dual effect of suramin on calcium fluxes across sarcoplasmic reticulum vesicle membranes.
      J T Emmick, S Kwon, K R Bidasee, K T Besch and H R Besch
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 717-724;
  5. Endoh, M

    1. You have access
      Dissociation of the positive inotropic effect of methoxamine from the hydrolysis of phosphoinositide in rabbit ventricular myocardium: a comparison with the effects of phenylephrine and the subtype of the alpha-1 adrenoceptor involved.
      H T Yang and M Endoh
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 732-742;
  6. Erdmann, E

    1. You have access
      Inotropic effect of the cardioprotective agent 2,3-butanedione monoxime in failing and nonfailing human myocardium.
      R H Schwinger, M Böhm, A Koch, I Morano, J C Rüegg and E Erdmann
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 778-786;

F

  1. Fang, S N

    1. You have access
      SNF9007: a novel analgesic that acts simultaneously at delta 1, delta 2 and mu opioid receptors.
      C L Williams, G C Rosenfeld, N Dafny, S N Fang, V J Hruby, G Bowden, C A Cullinan and T F Burks
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 750-755;
  2. Fischer, C

    1. You have access
      Dexfenfluramine and serotonin neurotoxicity: further preclinical evidence that clinical caution is indicated.
      U McCann, G Hatzidimitriou, A Ridenour, C Fischer, J Yuan, J Katz and G Ricaurte
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 792-798;
  3. Fix, J A

    1. You have access
      In vitro and in vivo analysis of the mechanism of absorption enhancement by palmitoylcarnitine.
      J H Hochman, J A Fix and E L LeCluyse
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 813-822;
  4. Foultier, M T

    1. You have access
      Malondialdehyde dosimetry in laser-irradiated tissues sensitized by hematoporphyrin derivative.
      C Perret, M T Foultier, V Vonarx-Coinsman, O Quancard, A Combre and T Patrice
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 787-791;
  5. Fournier, A

    1. You have access
      Binding profile of a selective calcitonin gene-related peptide (CGRP) receptor antagonist ligand, [125I-Tyr]hCGRP8-37, in rat brain and peripheral tissues.
      D Van Rossum, D P Ménard, A Fournier, S St-Pierre and R Quirion
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 846-853;
  6. France, C P

    1. You have access
      Naltrexone antagonizes the analgesic and immunosuppressive effects of morphine in mice.
      D J Carr, L R Gerak and C P France
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 693-698;
  7. Fritzsch, G

    1. You have access
      Polysubstrates: substances that interact with renal contraluminal PAH, sulfate, and NMeN transport: sulfamoyl-, sulfonylurea-, thiazide- and benzeneamino-carboxylate (nicotinate) compounds.
      K J Ullrich, G Fritzsch, G Rumrich and C David
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 684-692;

G

  1. Gagnon, M J

    1. You have access
      Antagonism of nitrous oxide antinociception in the rat hot plate test by site-specific mu and epsilon opioid receptor blockade.
      B L Hodges, M J Gagnon, T R Gillespie, J R Breneisen, D F O'Leary, S Hara and R M Quock
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 596-600;
    2. You have access
      Inhibitors of nitric oxide synthesis antagonize nitrous oxide antinociception in mice and rats.
      C E McDonald, M J Gagnon, E A Ellenberger, B L Hodges, J K Ream, S A Tousman and R M Quock
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 601-608;
  2. Geiger, J D

    1. You have access
      Chlorotyrosine exerts renal effects and antagonizes renal and gastric responses to atrial natriuretic peptide.
      Q M Chen, D D Smyth, J K McKenzie, G B Glavin, J G Gu, J D Geiger and F S LaBella
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 709-716;
  3. Gerak, L R

    1. You have access
      Naltrexone antagonizes the analgesic and immunosuppressive effects of morphine in mice.
      D J Carr, L R Gerak and C P France
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 693-698;
  4. Ghanayem, B I

    1. You have access
      Investigation of methacrylonitrile metabolism and the metabolic basis for the differences in its toxicity in rats and mice.
      B I Ghanayem, I M Sanchez and L T Burka
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 581-588;
  5. Gillespie, T R

    1. You have access
      Antagonism of nitrous oxide antinociception in the rat hot plate test by site-specific mu and epsilon opioid receptor blockade.
      B L Hodges, M J Gagnon, T R Gillespie, J R Breneisen, D F O'Leary, S Hara and R M Quock
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 596-600;
  6. Glavin, G B

    1. You have access
      Chlorotyrosine exerts renal effects and antagonizes renal and gastric responses to atrial natriuretic peptide.
      Q M Chen, D D Smyth, J K McKenzie, G B Glavin, J G Gu, J D Geiger and F S LaBella
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 709-716;
  7. Glowinski, J

    1. You have access
      Muscarinic cholinergic agonists stimulate arachidonic acid release from mouse striatal neurons in primary culture.
      M Tencé, J Cordier, J Premont and J Glowinski
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 646-653;
  8. Graham, S H

    1. You have access
      Neuroprotective effects of a use-dependent blocker of voltage-dependent sodium channels, BW619C89, in rat middle cerebral artery occlusion.
      S H Graham, J Chen, J Lan, M J Leach and R P Simon
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 854-859;
  9. Greven, J

    1. You have access
      The renal basolateral transport system for organic anions: properties of the regulation mechanism.
      H Hohage, M Löhr, U Querl and J Greven
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 659-664;
  10. Griffiths, N M

    1. You have access
      Active intestinal secretion of the fluoroquinolone antibacterials ciprofloxacin, norfloxacin and pefloxacin; a common secretory pathway?
      N M Griffiths, B H Hirst and N L Simmons
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 496-502;
  11. Gross, G J

    1. You have access
      Stimulatory and inhibitory action of nitric oxide donor agents vs. nitrovasodilators on reactive oxygen production by isolated polymorphonuclear leukocytes.
      G M Pieper, G A Clarke and G J Gross
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 451-456;
  12. Grossie, J

    1. You have access
      Dopamine inhibits a sustained calcium current through activation of alpha adrenergic receptors and a GTP-binding protein in adult rat sympathetic neurons.
      L G Aguayo and J Grossie
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 503-508;
  13. Grover, G J

    1. You have access
      The cardioprotective and electrophysiological effects of cromakalim are attenuated by meclofenamate through a cyclooxygenase-independent mechanism.
      G J Grover, A J D'Alonzo, P G Sleph, S Dzwonczyk, T A Hess and R B Darbenzio
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 536-540;
  14. Gu, J G

    1. You have access
      Chlorotyrosine exerts renal effects and antagonizes renal and gastric responses to atrial natriuretic peptide.
      Q M Chen, D D Smyth, J K McKenzie, G B Glavin, J G Gu, J D Geiger and F S LaBella
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 709-716;
  15. Guillonneau, C

    1. You have access
      S 12340: a potent inhibitor of the oxidative modification of low-density lipoprotein in vitro and ex vivo in WHHL rabbits.
      C Breugnot, S Privat, C Guillonneau, G Regnier, F Bouzom, J P Vilaine and A Lenaers
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 515-520;

H

  1. Hanson, G R

    1. You have access
      Induction of neurotensin and c-fos mRNA in distinct subregions of rat neostriatum after acute methamphetamine: comparison with acute haloperidol effects.
      K M Merchant, G R Hanson and D M Dorsa
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 806-812;
  2. Hara, H

    1. You have access
      Sigma receptor-mediated effects of a new antiulcer agent, KB-5492, on experimental gastric mucosal lesions and gastric alkaline secretion in rats.
      H Hara, K Tanaka, Y Harada and T Sukamoto
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 799-805;
  3. Hara, S

    1. You have access
      Antagonism of nitrous oxide antinociception in the rat hot plate test by site-specific mu and epsilon opioid receptor blockade.
      B L Hodges, M J Gagnon, T R Gillespie, J R Breneisen, D F O'Leary, S Hara and R M Quock
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 596-600;
  4. Harada, Y

    1. You have access
      Sigma receptor-mediated effects of a new antiulcer agent, KB-5492, on experimental gastric mucosal lesions and gastric alkaline secretion in rats.
      H Hara, K Tanaka, Y Harada and T Sukamoto
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 799-805;
  5. Hasegawa, T

    1. You have access
      Cholecystokinin-related peptides, after systemic or central administration, prevent carbon monoxide-induced amnesia in mice.
      T Maurice, M Hiramatsu, T Kameyama, T Hasegawa and T Nabeshima
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 665-673;
  6. Hashimoto, S

    1. You have access
      Effects of vasoactive substances on the pig isolated hepatic lymph vessels.
      S Hashimoto, Y Kawai and T Ohhashi
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 482-488;
  7. Hatzidimitriou, G

    1. You have access
      Dexfenfluramine and serotonin neurotoxicity: further preclinical evidence that clinical caution is indicated.
      U McCann, G Hatzidimitriou, A Ridenour, C Fischer, J Yuan, J Katz and G Ricaurte
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 792-798;
  8. Heinrichs, S C

    1. You have access
      Characterization of a novel and potent corticotropin-releasing factor antagonist in rats.
      F Menzaghi, R L Howard, S C Heinrichs, W Vale, J Rivier and G F Koob
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 564-572;
  9. Henthorn, T K

    1. You have access
      A recirculatory pharmacokinetic model describing the circulatory mixing, tissue distribution and elimination of antipyrine in dogs.
      T C Krejcie, T K Henthorn, C A Shanks and M J Avram
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 609-616;
  10. Herbert, J M

    1. You have access
      Binding of [3H]-2-methylthio ADP to rat platelets--effect of clopidogrel and ticlopidine.
      P Savi, M C Laplace, J P Maffrand and J M Herbert
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 772-777;
  11. Hess, T A

    1. You have access
      The cardioprotective and electrophysiological effects of cromakalim are attenuated by meclofenamate through a cyclooxygenase-independent mechanism.
      G J Grover, A J D'Alonzo, P G Sleph, S Dzwonczyk, T A Hess and R B Darbenzio
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 536-540;
  12. Hiramatsu, M

    1. You have access
      Cholecystokinin-related peptides, after systemic or central administration, prevent carbon monoxide-induced amnesia in mice.
      T Maurice, M Hiramatsu, T Kameyama, T Hasegawa and T Nabeshima
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 665-673;
  13. Hirst, B H

    1. You have access
      Active intestinal secretion of the fluoroquinolone antibacterials ciprofloxacin, norfloxacin and pefloxacin; a common secretory pathway?
      N M Griffiths, B H Hirst and N L Simmons
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 496-502;
  14. Hisaki, K

    1. You have access
      The effects of NG-nitro-L-arginine, a nitric oxide synthase inhibitor, on norepinephrine overflow and antidiuresis induced by stimulation of renal nerves in anesthetized dogs.
      Y Egi, Y Matsumura, S Murata, T Umekawa, K Hisaki, M Takaoka and S Morimoto
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 529-535;
  15. Hochman, J H

    1. You have access
      In vitro and in vivo analysis of the mechanism of absorption enhancement by palmitoylcarnitine.
      J H Hochman, J A Fix and E L LeCluyse
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 813-822;
  16. Hodges, B L

    1. You have access
      Antagonism of nitrous oxide antinociception in the rat hot plate test by site-specific mu and epsilon opioid receptor blockade.
      B L Hodges, M J Gagnon, T R Gillespie, J R Breneisen, D F O'Leary, S Hara and R M Quock
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 596-600;
    2. You have access
      Inhibitors of nitric oxide synthesis antagonize nitrous oxide antinociception in mice and rats.
      C E McDonald, M J Gagnon, E A Ellenberger, B L Hodges, J K Ream, S A Tousman and R M Quock
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 601-608;
  17. Hoffmann, I S

    1. You have access
      Behavior of mesocortical dopamine terminals during single and repetitive stimulation: comparison with nigrostriatal neurons.
      E Agneter, I S Hoffmann, E A Singer and L X Cubeddu
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 470-476;
  18. Hohage, H

    1. You have access
      The renal basolateral transport system for organic anions: properties of the regulation mechanism.
      H Hohage, M Löhr, U Querl and J Greven
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 659-664;
  19. Hoogerkamp, A

    1. You have access
      Characterization of the pharmacodynamics of several antiepileptic drugs in a direct cortical stimulation model of anticonvulsant effect in the rat.
      A Hoogerkamp, P W Vis, M Danhof and R A Voskuyl
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 521-528;
  20. Howard, R L

    1. You have access
      Characterization of a novel and potent corticotropin-releasing factor antagonist in rats.
      F Menzaghi, R L Howard, S C Heinrichs, W Vale, J Rivier and G F Koob
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 564-572;
  21. Hruby, V J

    1. You have access
      SNF9007: a novel analgesic that acts simultaneously at delta 1, delta 2 and mu opioid receptors.
      C L Williams, G C Rosenfeld, N Dafny, S N Fang, V J Hruby, G Bowden, C A Cullinan and T F Burks
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 750-755;

I

  1. Inoue, S

    1. You have access
      Novel rapid- and short-acting hypoglycemic agent, a calcium(2s)-2-benzyl-3-(cis-hexahydro-2-isoindolinylcarbonyl) propionate (KAD-1229) that acts on the sulfonylurea receptor: comparison of effects between KAD-1229 and gliclazide.
      H Ohnota, T Koizumi, N Tsutsumi, M Kobayashi, S Inoue and F Sato
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 489-495;
  2. Ito, H

    1. You have access
      Pharmacological profile of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo- 5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo.
      A Nishida, K Miyata, R Tsutsumi, H Yuki, S Akuzawa, A Kobayashi, T Kamato, H Ito, M Yamano and Y Katuyama
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 725-731;
  3. Ito, M

    1. You have access
      Nephrosis augments contractile response to adrenoceptor agonists by the decrease in release of endothelium-derived relaxing factor from the endothelial cells.
      M Ito, A Naruse, I Yamamoto, M Oguri, Y Suzuki, N Satake and S Shibata
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 589-595;
  4. Iwamoto, E T

    1. You have access
      Pharmacological evidence that nitric oxide mediates the antinociception produced by muscarinic agonists in the rostral ventral medulla of rats.
      E T Iwamoto and L Marion
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 699-708;

J

  1. Joyner, C M

    1. You have access
      Withdrawal from continuous or intermittent cocaine administration: changes in D2 receptor function.
      G R King, E H Ellinwood, C Silvia, C M Joyner, Z Xue, M G Caron and T H Lee
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 743-749;
  2. Junien, J L

    1. You have access
      Tonic regulation of mouse ileal ion transport by nitric oxide.
      R K Rao, P J Riviere, X Pascaud, J L Junien and F Porreca
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 626-631;
  3. Jurkiewicz, N K

    1. You have access
      Cardiac electrophysiologic and antiarrhythmic actions of two long-acting spirobenzopyran piperidine class III agents, L-702,958 and L-706,000 [MK-499].
      J J Lynch, A A Wallace, R F Stupienski, E P Baskin, C M Beare, S D Appleby, J J Salata, N K Jurkiewicz, M C Sanguinetti and R B Stein
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 541-554;

K

  1. Kamato, T

    1. You have access
      Pharmacological profile of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo- 5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo.
      A Nishida, K Miyata, R Tsutsumi, H Yuki, S Akuzawa, A Kobayashi, T Kamato, H Ito, M Yamano and Y Katuyama
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 725-731;
  2. Kameyama, T

    1. You have access
      Cholecystokinin-related peptides, after systemic or central administration, prevent carbon monoxide-induced amnesia in mice.
      T Maurice, M Hiramatsu, T Kameyama, T Hasegawa and T Nabeshima
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 665-673;
  3. Katuyama, Y

    1. You have access
      Pharmacological profile of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo- 5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo.
      A Nishida, K Miyata, R Tsutsumi, H Yuki, S Akuzawa, A Kobayashi, T Kamato, H Ito, M Yamano and Y Katuyama
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 725-731;
  4. Katz, J

    1. You have access
      Dexfenfluramine and serotonin neurotoxicity: further preclinical evidence that clinical caution is indicated.
      U McCann, G Hatzidimitriou, A Ridenour, C Fischer, J Yuan, J Katz and G Ricaurte
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 792-798;
  5. Kawai, Y

    1. You have access
      Effects of vasoactive substances on the pig isolated hepatic lymph vessels.
      S Hashimoto, Y Kawai and T Ohhashi
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 482-488;
  6. Khwaja, S

    1. You have access
      Cimetidine prevents alcoholic hepatic injury in the intragastric feeding rat model.
      A A Nanji, S Zhao, S Khwaja, S M Sadrzadeh and D J Waxman
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 832-837;
  7. King, G R

    1. You have access
      Withdrawal from continuous or intermittent cocaine administration: changes in D2 receptor function.
      G R King, E H Ellinwood, C Silvia, C M Joyner, Z Xue, M G Caron and T H Lee
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 743-749;
  8. Knie, B

    1. You have access
      Arylamine N-acetyltransferase activity of the human placenta.
      L O Derewlany, B Knie and G Koren
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 756-760;
    2. You have access
      Human placental transfer and metabolism of p-aminobenzoic acid.
      L O Derewlany, B Knie and G Koren
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 761-765;
  9. Knuepfer, M M

    1. You have access
      Causes of differential cardiovascular sensitivity to cocaine. I: Studies in conscious rats.
      C A Branch and M M Knuepfer
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 674-683;
  10. Kobayashi, A

    1. You have access
      Pharmacological profile of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo- 5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo.
      A Nishida, K Miyata, R Tsutsumi, H Yuki, S Akuzawa, A Kobayashi, T Kamato, H Ito, M Yamano and Y Katuyama
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 725-731;
  11. Kobayashi, M

    1. You have access
      Novel rapid- and short-acting hypoglycemic agent, a calcium(2s)-2-benzyl-3-(cis-hexahydro-2-isoindolinylcarbonyl) propionate (KAD-1229) that acts on the sulfonylurea receptor: comparison of effects between KAD-1229 and gliclazide.
      H Ohnota, T Koizumi, N Tsutsumi, M Kobayashi, S Inoue and F Sato
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 489-495;
  12. Koch, A

    1. You have access
      Inotropic effect of the cardioprotective agent 2,3-butanedione monoxime in failing and nonfailing human myocardium.
      R H Schwinger, M Böhm, A Koch, I Morano, J C Rüegg and E Erdmann
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 778-786;
  13. Koizumi, T

    1. You have access
      Novel rapid- and short-acting hypoglycemic agent, a calcium(2s)-2-benzyl-3-(cis-hexahydro-2-isoindolinylcarbonyl) propionate (KAD-1229) that acts on the sulfonylurea receptor: comparison of effects between KAD-1229 and gliclazide.
      H Ohnota, T Koizumi, N Tsutsumi, M Kobayashi, S Inoue and F Sato
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 489-495;
  14. Konkoy, C S

    1. You have access
      Acute administration of neuroleptics decreases neurotensin metabolism on intact, regional rat brain slices.
      C S Konkoy, S M Waters and T P Davis
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 555-563;
  15. Koob, G F

    1. You have access
      Characterization of a novel and potent corticotropin-releasing factor antagonist in rats.
      F Menzaghi, R L Howard, S C Heinrichs, W Vale, J Rivier and G F Koob
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 564-572;
  16. Koren, G

    1. You have access
      Arylamine N-acetyltransferase activity of the human placenta.
      L O Derewlany, B Knie and G Koren
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 756-760;
    2. You have access
      Human placental transfer and metabolism of p-aminobenzoic acid.
      L O Derewlany, B Knie and G Koren
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 761-765;
  17. Kostrubsky, V

    1. You have access
      Synergistic increases in rat hepatic cytochrome P450s by ethanol and isopentanol.
      C A Louis, S G Wood, V Kostrubsky, P R Sinclair and J F Sinclair
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 838-845;
  18. Krejcie, T C

    1. You have access
      A recirculatory pharmacokinetic model describing the circulatory mixing, tissue distribution and elimination of antipyrine in dogs.
      T C Krejcie, T K Henthorn, C A Shanks and M J Avram
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 609-616;
  19. Kwon, S

    1. You have access
      Dual effect of suramin on calcium fluxes across sarcoplasmic reticulum vesicle membranes.
      J T Emmick, S Kwon, K R Bidasee, K T Besch and H R Besch
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 717-724;

L

  1. LaBella, F S

    1. You have access
      Chlorotyrosine exerts renal effects and antagonizes renal and gastric responses to atrial natriuretic peptide.
      Q M Chen, D D Smyth, J K McKenzie, G B Glavin, J G Gu, J D Geiger and F S LaBella
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 709-716;
  2. Lan, J

    1. You have access
      Neuroprotective effects of a use-dependent blocker of voltage-dependent sodium channels, BW619C89, in rat middle cerebral artery occlusion.
      S H Graham, J Chen, J Lan, M J Leach and R P Simon
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 854-859;
  3. Laplace, M C

    1. You have access
      Binding of [3H]-2-methylthio ADP to rat platelets--effect of clopidogrel and ticlopidine.
      P Savi, M C Laplace, J P Maffrand and J M Herbert
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 772-777;
  4. Leach, M J

    1. You have access
      Neuroprotective effects of a use-dependent blocker of voltage-dependent sodium channels, BW619C89, in rat middle cerebral artery occlusion.
      S H Graham, J Chen, J Lan, M J Leach and R P Simon
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 854-859;
  5. LeCluyse, E L

    1. You have access
      In vitro and in vivo analysis of the mechanism of absorption enhancement by palmitoylcarnitine.
      J H Hochman, J A Fix and E L LeCluyse
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 813-822;
  6. Lee, T H

    1. You have access
      Withdrawal from continuous or intermittent cocaine administration: changes in D2 receptor function.
      G R King, E H Ellinwood, C Silvia, C M Joyner, Z Xue, M G Caron and T H Lee
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 743-749;
  7. Legrain, S

    1. You have access
      High lipophilicity decreases drug transport across intestinal epithelial cells.
      P Wils, A Warnery, V Phung-Ba, S Legrain and D Scherman
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 654-658;
  8. Lenaers, A

    1. You have access
      S 12340: a potent inhibitor of the oxidative modification of low-density lipoprotein in vitro and ex vivo in WHHL rabbits.
      C Breugnot, S Privat, C Guillonneau, G Regnier, F Bouzom, J P Vilaine and A Lenaers
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 515-520;
  9. Löhr, M

    1. You have access
      The renal basolateral transport system for organic anions: properties of the regulation mechanism.
      H Hohage, M Löhr, U Querl and J Greven
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 659-664;
  10. Louis, C A

    1. You have access
      Synergistic increases in rat hepatic cytochrome P450s by ethanol and isopentanol.
      C A Louis, S G Wood, V Kostrubsky, P R Sinclair and J F Sinclair
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 838-845;
  11. Lynch, J J

    1. You have access
      Cardiac electrophysiologic and antiarrhythmic actions of two long-acting spirobenzopyran piperidine class III agents, L-702,958 and L-706,000 [MK-499].
      J J Lynch, A A Wallace, R F Stupienski, E P Baskin, C M Beare, S D Appleby, J J Salata, N K Jurkiewicz, M C Sanguinetti and R B Stein
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 541-554;

M

  1. Maffrand, J P

    1. You have access
      Binding of [3H]-2-methylthio ADP to rat platelets--effect of clopidogrel and ticlopidine.
      P Savi, M C Laplace, J P Maffrand and J M Herbert
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 772-777;
  2. Marion, L

    1. You have access
      Pharmacological evidence that nitric oxide mediates the antinociception produced by muscarinic agonists in the rostral ventral medulla of rats.
      E T Iwamoto and L Marion
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 699-708;
  3. Matsumura, Y

    1. You have access
      The effects of NG-nitro-L-arginine, a nitric oxide synthase inhibitor, on norepinephrine overflow and antidiuresis induced by stimulation of renal nerves in anesthetized dogs.
      Y Egi, Y Matsumura, S Murata, T Umekawa, K Hisaki, M Takaoka and S Morimoto
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 529-535;
    2. You have access
      Platelets-induced stimulation of endothelin-1 production and inhibition by phosphoramidon.
      T Umekawa, Y Matsumura, N Yoshimura, S Murata, K Takada, Y Tsukahara, M Takaoka and S Morimoto
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 860-866;
  4. Maurice, T

    1. You have access
      Cholecystokinin-related peptides, after systemic or central administration, prevent carbon monoxide-induced amnesia in mice.
      T Maurice, M Hiramatsu, T Kameyama, T Hasegawa and T Nabeshima
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 665-673;
  5. McCann, U

    1. You have access
      Dexfenfluramine and serotonin neurotoxicity: further preclinical evidence that clinical caution is indicated.
      U McCann, G Hatzidimitriou, A Ridenour, C Fischer, J Yuan, J Katz and G Ricaurte
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 792-798;
  6. McDonald, C E

    1. You have access
      Inhibitors of nitric oxide synthesis antagonize nitrous oxide antinociception in mice and rats.
      C E McDonald, M J Gagnon, E A Ellenberger, B L Hodges, J K Ream, S A Tousman and R M Quock
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 601-608;
  7. McKenzie, J K

    1. You have access
      Chlorotyrosine exerts renal effects and antagonizes renal and gastric responses to atrial natriuretic peptide.
      Q M Chen, D D Smyth, J K McKenzie, G B Glavin, J G Gu, J D Geiger and F S LaBella
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 709-716;
  8. Ménard, D P

    1. You have access
      Binding profile of a selective calcitonin gene-related peptide (CGRP) receptor antagonist ligand, [125I-Tyr]hCGRP8-37, in rat brain and peripheral tissues.
      D Van Rossum, D P Ménard, A Fournier, S St-Pierre and R Quirion
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 846-853;
  9. Menzaghi, F

    1. You have access
      Characterization of a novel and potent corticotropin-releasing factor antagonist in rats.
      F Menzaghi, R L Howard, S C Heinrichs, W Vale, J Rivier and G F Koob
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 564-572;
  10. Merchant, K M

    1. You have access
      Induction of neurotensin and c-fos mRNA in distinct subregions of rat neostriatum after acute methamphetamine: comparison with acute haloperidol effects.
      K M Merchant, G R Hanson and D M Dorsa
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 806-812;
  11. Miyata, K

    1. You have access
      Pharmacological profile of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo- 5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo.
      A Nishida, K Miyata, R Tsutsumi, H Yuki, S Akuzawa, A Kobayashi, T Kamato, H Ito, M Yamano and Y Katuyama
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 725-731;
  12. Montrucchio, G

    1. You have access
      Role of platelet-activating factor (PAF) in oxygen radical-induced cardiac dysfunction.
      G Alloatti, G Montrucchio and G Camussi
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 766-771;
  13. Morano, I

    1. You have access
      Inotropic effect of the cardioprotective agent 2,3-butanedione monoxime in failing and nonfailing human myocardium.
      R H Schwinger, M Böhm, A Koch, I Morano, J C Rüegg and E Erdmann
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 778-786;
  14. Morimoto, S

    1. You have access
      The effects of NG-nitro-L-arginine, a nitric oxide synthase inhibitor, on norepinephrine overflow and antidiuresis induced by stimulation of renal nerves in anesthetized dogs.
      Y Egi, Y Matsumura, S Murata, T Umekawa, K Hisaki, M Takaoka and S Morimoto
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 529-535;
    2. You have access
      Platelets-induced stimulation of endothelin-1 production and inhibition by phosphoramidon.
      T Umekawa, Y Matsumura, N Yoshimura, S Murata, K Takada, Y Tsukahara, M Takaoka and S Morimoto
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 860-866;
  15. Morin, D

    1. You have access
      Covalent interactions of reactive naphthalene metabolites with proteins.
      M Cho, C Chichester, D Morin, C Plopper and A Buckpitt
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 881-889;
  16. Murata, S

    1. You have access
      The effects of NG-nitro-L-arginine, a nitric oxide synthase inhibitor, on norepinephrine overflow and antidiuresis induced by stimulation of renal nerves in anesthetized dogs.
      Y Egi, Y Matsumura, S Murata, T Umekawa, K Hisaki, M Takaoka and S Morimoto
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 529-535;
    2. You have access
      Platelets-induced stimulation of endothelin-1 production and inhibition by phosphoramidon.
      T Umekawa, Y Matsumura, N Yoshimura, S Murata, K Takada, Y Tsukahara, M Takaoka and S Morimoto
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 860-866;

N

  1. Nabeshima, T

    1. You have access
      Cholecystokinin-related peptides, after systemic or central administration, prevent carbon monoxide-induced amnesia in mice.
      T Maurice, M Hiramatsu, T Kameyama, T Hasegawa and T Nabeshima
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 665-673;
  2. Nakada-Kometani, Y

    1. You have access
      Chronic pharmacological activities of the novel anxiolytic beta-carboline abecarnil in rats.
      M Ozawa, K Sugimachi, Y Nakada-Kometani, T Akai and M Yamaguchi
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 457-462;
  3. Nanji, A A

    1. You have access
      The oral iron chelator, 1,2-dimethyl-3-hydroxypyrid-4-one reduces hepatic-free iron, lipid peroxidation and fat accumulation in chronically ethanol-fed rats.
      S M Sadrzadeh, A A Nanji and P L Price
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 632-636;
    2. You have access
      Cimetidine prevents alcoholic hepatic injury in the intragastric feeding rat model.
      A A Nanji, S Zhao, S Khwaja, S M Sadrzadeh and D J Waxman
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 832-837;
  4. Naruse, A

    1. You have access
      Nephrosis augments contractile response to adrenoceptor agonists by the decrease in release of endothelium-derived relaxing factor from the endothelial cells.
      M Ito, A Naruse, I Yamamoto, M Oguri, Y Suzuki, N Satake and S Shibata
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 589-595;
  5. Nishida, A

    1. You have access
      Pharmacological profile of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo- 5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo.
      A Nishida, K Miyata, R Tsutsumi, H Yuki, S Akuzawa, A Kobayashi, T Kamato, H Ito, M Yamano and Y Katuyama
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 725-731;
  6. Nishio, S J

    1. You have access
      Elevated susceptibility to 4-ipomeanol cytotoxicity in immature Clara cells of neonatal rabbits.
      C G Plopper, A J Weir, S J Nishio, A Chang, M Voit, R M Philpot and A R Buckpitt
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 867-880;

O

  1. O'Leary, D F

    1. You have access
      Antagonism of nitrous oxide antinociception in the rat hot plate test by site-specific mu and epsilon opioid receptor blockade.
      B L Hodges, M J Gagnon, T R Gillespie, J R Breneisen, D F O'Leary, S Hara and R M Quock
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 596-600;
  2. Oguri, M

    1. You have access
      Nephrosis augments contractile response to adrenoceptor agonists by the decrease in release of endothelium-derived relaxing factor from the endothelial cells.
      M Ito, A Naruse, I Yamamoto, M Oguri, Y Suzuki, N Satake and S Shibata
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 589-595;
  3. Ohhashi, T

    1. You have access
      Effects of vasoactive substances on the pig isolated hepatic lymph vessels.
      S Hashimoto, Y Kawai and T Ohhashi
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 482-488;
  4. Ohnota, H

    1. You have access
      Novel rapid- and short-acting hypoglycemic agent, a calcium(2s)-2-benzyl-3-(cis-hexahydro-2-isoindolinylcarbonyl) propionate (KAD-1229) that acts on the sulfonylurea receptor: comparison of effects between KAD-1229 and gliclazide.
      H Ohnota, T Koizumi, N Tsutsumi, M Kobayashi, S Inoue and F Sato
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 489-495;
  5. Ohtsuyama, M

    1. You have access
      Stimulation of Cl conductance by minoxidil sulfate and K conductance by minoxidil in eccrine clear cells.
      M Ohtsuyama, F Sato, T Toyomoto and K Sato
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 823-831;
  6. Ozawa, M

    1. You have access
      Chronic pharmacological activities of the novel anxiolytic beta-carboline abecarnil in rats.
      M Ozawa, K Sugimachi, Y Nakada-Kometani, T Akai and M Yamaguchi
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 457-462;

P

  1. Pang, C C

    1. You have access
      Effects of adrenalectomy and chemical sympathectomy on pressor and tachycardic responses to diphenyleneiodonium.
      Y X Wang and C C Pang
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 463-469;
  2. Pascaud, X

    1. You have access
      Tonic regulation of mouse ileal ion transport by nitric oxide.
      R K Rao, P J Riviere, X Pascaud, J L Junien and F Porreca
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 626-631;
  3. Patrice, T

    1. You have access
      Malondialdehyde dosimetry in laser-irradiated tissues sensitized by hematoporphyrin derivative.
      C Perret, M T Foultier, V Vonarx-Coinsman, O Quancard, A Combre and T Patrice
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 787-791;
  4. Perret, C

    1. You have access
      Malondialdehyde dosimetry in laser-irradiated tissues sensitized by hematoporphyrin derivative.
      C Perret, M T Foultier, V Vonarx-Coinsman, O Quancard, A Combre and T Patrice
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 787-791;
  5. Pfaffendorf, M

    1. You have access
      Different types of angiotensin II receptor antagonism induced by BIBS 222 in the rat portal vein and rabbit aorta; the influence of receptor reserve.
      J S Zhang, J C Van Meel, M Pfaffendorf and P A Van Zwieten
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 509-514;
  6. Philpot, R M

    1. You have access
      Elevated susceptibility to 4-ipomeanol cytotoxicity in immature Clara cells of neonatal rabbits.
      C G Plopper, A J Weir, S J Nishio, A Chang, M Voit, R M Philpot and A R Buckpitt
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 867-880;
  7. Phung-Ba, V

    1. You have access
      High lipophilicity decreases drug transport across intestinal epithelial cells.
      P Wils, A Warnery, V Phung-Ba, S Legrain and D Scherman
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 654-658;
  8. Pieper, G M

    1. You have access
      Stimulatory and inhibitory action of nitric oxide donor agents vs. nitrovasodilators on reactive oxygen production by isolated polymorphonuclear leukocytes.
      G M Pieper, G A Clarke and G J Gross
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 451-456;
  9. Plopper, C

    1. You have access
      Covalent interactions of reactive naphthalene metabolites with proteins.
      M Cho, C Chichester, D Morin, C Plopper and A Buckpitt
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 881-889;
  10. Plopper, C G

    1. You have access
      Elevated susceptibility to 4-ipomeanol cytotoxicity in immature Clara cells of neonatal rabbits.
      C G Plopper, A J Weir, S J Nishio, A Chang, M Voit, R M Philpot and A R Buckpitt
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 867-880;
  11. Porreca, F

    1. You have access
      Tonic regulation of mouse ileal ion transport by nitric oxide.
      R K Rao, P J Riviere, X Pascaud, J L Junien and F Porreca
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 626-631;
  12. Premont, J

    1. You have access
      Muscarinic cholinergic agonists stimulate arachidonic acid release from mouse striatal neurons in primary culture.
      M Tencé, J Cordier, J Premont and J Glowinski
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 646-653;
  13. Price, P L

    1. You have access
      The oral iron chelator, 1,2-dimethyl-3-hydroxypyrid-4-one reduces hepatic-free iron, lipid peroxidation and fat accumulation in chronically ethanol-fed rats.
      S M Sadrzadeh, A A Nanji and P L Price
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 632-636;
  14. Privat, S

    1. You have access
      S 12340: a potent inhibitor of the oxidative modification of low-density lipoprotein in vitro and ex vivo in WHHL rabbits.
      C Breugnot, S Privat, C Guillonneau, G Regnier, F Bouzom, J P Vilaine and A Lenaers
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 515-520;

Q

  1. Quancard, O

    1. You have access
      Malondialdehyde dosimetry in laser-irradiated tissues sensitized by hematoporphyrin derivative.
      C Perret, M T Foultier, V Vonarx-Coinsman, O Quancard, A Combre and T Patrice
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 787-791;
  2. Querl, U

    1. You have access
      The renal basolateral transport system for organic anions: properties of the regulation mechanism.
      H Hohage, M Löhr, U Querl and J Greven
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 659-664;
  3. Quirion, R

    1. You have access
      Binding profile of a selective calcitonin gene-related peptide (CGRP) receptor antagonist ligand, [125I-Tyr]hCGRP8-37, in rat brain and peripheral tissues.
      D Van Rossum, D P Ménard, A Fournier, S St-Pierre and R Quirion
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 846-853;
  4. Quock, R M

    1. You have access
      Antagonism of nitrous oxide antinociception in the rat hot plate test by site-specific mu and epsilon opioid receptor blockade.
      B L Hodges, M J Gagnon, T R Gillespie, J R Breneisen, D F O'Leary, S Hara and R M Quock
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 596-600;
    2. You have access
      Inhibitors of nitric oxide synthesis antagonize nitrous oxide antinociception in mice and rats.
      C E McDonald, M J Gagnon, E A Ellenberger, B L Hodges, J K Ream, S A Tousman and R M Quock
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 601-608;

R

  1. Rao, R K

    1. You have access
      Tonic regulation of mouse ileal ion transport by nitric oxide.
      R K Rao, P J Riviere, X Pascaud, J L Junien and F Porreca
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 626-631;
  2. Ream, J K

    1. You have access
      Inhibitors of nitric oxide synthesis antagonize nitrous oxide antinociception in mice and rats.
      C E McDonald, M J Gagnon, E A Ellenberger, B L Hodges, J K Ream, S A Tousman and R M Quock
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 601-608;
  3. Regnier, G

    1. You have access
      S 12340: a potent inhibitor of the oxidative modification of low-density lipoprotein in vitro and ex vivo in WHHL rabbits.
      C Breugnot, S Privat, C Guillonneau, G Regnier, F Bouzom, J P Vilaine and A Lenaers
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 515-520;
  4. Ricaurte, G

    1. You have access
      Dexfenfluramine and serotonin neurotoxicity: further preclinical evidence that clinical caution is indicated.
      U McCann, G Hatzidimitriou, A Ridenour, C Fischer, J Yuan, J Katz and G Ricaurte
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 792-798;
  5. Ridenour, A

    1. You have access
      Dexfenfluramine and serotonin neurotoxicity: further preclinical evidence that clinical caution is indicated.
      U McCann, G Hatzidimitriou, A Ridenour, C Fischer, J Yuan, J Katz and G Ricaurte
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 792-798;
  6. Rivier, J

    1. You have access
      Characterization of a novel and potent corticotropin-releasing factor antagonist in rats.
      F Menzaghi, R L Howard, S C Heinrichs, W Vale, J Rivier and G F Koob
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 564-572;
  7. Riviere, P J

    1. You have access
      Tonic regulation of mouse ileal ion transport by nitric oxide.
      R K Rao, P J Riviere, X Pascaud, J L Junien and F Porreca
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 626-631;
  8. Rosenfeld, G C

    1. You have access
      SNF9007: a novel analgesic that acts simultaneously at delta 1, delta 2 and mu opioid receptors.
      C L Williams, G C Rosenfeld, N Dafny, S N Fang, V J Hruby, G Bowden, C A Cullinan and T F Burks
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 750-755;
  9. Rüegg, J C

    1. You have access
      Inotropic effect of the cardioprotective agent 2,3-butanedione monoxime in failing and nonfailing human myocardium.
      R H Schwinger, M Böhm, A Koch, I Morano, J C Rüegg and E Erdmann
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 778-786;
  10. Rumrich, G

    1. You have access
      Polysubstrates: substances that interact with renal contraluminal PAH, sulfate, and NMeN transport: sulfamoyl-, sulfonylurea-, thiazide- and benzeneamino-carboxylate (nicotinate) compounds.
      K J Ullrich, G Fritzsch, G Rumrich and C David
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 684-692;

S

  1. Sadrzadeh, S M

    1. You have access
      The oral iron chelator, 1,2-dimethyl-3-hydroxypyrid-4-one reduces hepatic-free iron, lipid peroxidation and fat accumulation in chronically ethanol-fed rats.
      S M Sadrzadeh, A A Nanji and P L Price
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 632-636;
    2. You have access
      Cimetidine prevents alcoholic hepatic injury in the intragastric feeding rat model.
      A A Nanji, S Zhao, S Khwaja, S M Sadrzadeh and D J Waxman
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 832-837;
  2. Salata, J J

    1. You have access
      Cardiac electrophysiologic and antiarrhythmic actions of two long-acting spirobenzopyran piperidine class III agents, L-702,958 and L-706,000 [MK-499].
      J J Lynch, A A Wallace, R F Stupienski, E P Baskin, C M Beare, S D Appleby, J J Salata, N K Jurkiewicz, M C Sanguinetti and R B Stein
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 541-554;
  3. Sanchez, I M

    1. You have access
      Investigation of methacrylonitrile metabolism and the metabolic basis for the differences in its toxicity in rats and mice.
      B I Ghanayem, I M Sanchez and L T Burka
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 581-588;
  4. Sanguinetti, M C

    1. You have access
      Cardiac electrophysiologic and antiarrhythmic actions of two long-acting spirobenzopyran piperidine class III agents, L-702,958 and L-706,000 [MK-499].
      J J Lynch, A A Wallace, R F Stupienski, E P Baskin, C M Beare, S D Appleby, J J Salata, N K Jurkiewicz, M C Sanguinetti and R B Stein
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 541-554;
  5. Satake, N

    1. You have access
      Nephrosis augments contractile response to adrenoceptor agonists by the decrease in release of endothelium-derived relaxing factor from the endothelial cells.
      M Ito, A Naruse, I Yamamoto, M Oguri, Y Suzuki, N Satake and S Shibata
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 589-595;
  6. Sato, F

    1. You have access
      Novel rapid- and short-acting hypoglycemic agent, a calcium(2s)-2-benzyl-3-(cis-hexahydro-2-isoindolinylcarbonyl) propionate (KAD-1229) that acts on the sulfonylurea receptor: comparison of effects between KAD-1229 and gliclazide.
      H Ohnota, T Koizumi, N Tsutsumi, M Kobayashi, S Inoue and F Sato
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 489-495;
    2. You have access
      Stimulation of Cl conductance by minoxidil sulfate and K conductance by minoxidil in eccrine clear cells.
      M Ohtsuyama, F Sato, T Toyomoto and K Sato
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 823-831;
  7. Sato, K

    1. You have access
      Stimulation of Cl conductance by minoxidil sulfate and K conductance by minoxidil in eccrine clear cells.
      M Ohtsuyama, F Sato, T Toyomoto and K Sato
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 823-831;
  8. Savi, P

    1. You have access
      Binding of [3H]-2-methylthio ADP to rat platelets--effect of clopidogrel and ticlopidine.
      P Savi, M C Laplace, J P Maffrand and J M Herbert
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 772-777;
  9. Scherman, D

    1. You have access
      High lipophilicity decreases drug transport across intestinal epithelial cells.
      P Wils, A Warnery, V Phung-Ba, S Legrain and D Scherman
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 654-658;
  10. Schwinger, R H

    1. You have access
      Inotropic effect of the cardioprotective agent 2,3-butanedione monoxime in failing and nonfailing human myocardium.
      R H Schwinger, M Böhm, A Koch, I Morano, J C Rüegg and E Erdmann
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 778-786;
  11. Shanks, C A

    1. You have access
      A recirculatory pharmacokinetic model describing the circulatory mixing, tissue distribution and elimination of antipyrine in dogs.
      T C Krejcie, T K Henthorn, C A Shanks and M J Avram
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 609-616;
  12. Sheldon, R

    1. You have access
      Interaction of drug metabolites with the class I antiarrhythmic drug receptor on rat cardiac myocytes.
      R Sheldon, E Thakore, L Wilson and H Duff
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 477-481;
  13. Shibata, S

    1. You have access
      Nephrosis augments contractile response to adrenoceptor agonists by the decrease in release of endothelium-derived relaxing factor from the endothelial cells.
      M Ito, A Naruse, I Yamamoto, M Oguri, Y Suzuki, N Satake and S Shibata
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 589-595;
  14. Silvia, C

    1. You have access
      Withdrawal from continuous or intermittent cocaine administration: changes in D2 receptor function.
      G R King, E H Ellinwood, C Silvia, C M Joyner, Z Xue, M G Caron and T H Lee
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 743-749;
  15. Simmons, N L

    1. You have access
      Active intestinal secretion of the fluoroquinolone antibacterials ciprofloxacin, norfloxacin and pefloxacin; a common secretory pathway?
      N M Griffiths, B H Hirst and N L Simmons
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 496-502;
  16. Simon, R P

    1. You have access
      Neuroprotective effects of a use-dependent blocker of voltage-dependent sodium channels, BW619C89, in rat middle cerebral artery occlusion.
      S H Graham, J Chen, J Lan, M J Leach and R P Simon
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 854-859;
  17. Sinclair, J F

    1. You have access
      Synergistic increases in rat hepatic cytochrome P450s by ethanol and isopentanol.
      C A Louis, S G Wood, V Kostrubsky, P R Sinclair and J F Sinclair
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 838-845;
  18. Sinclair, P R

    1. You have access
      Synergistic increases in rat hepatic cytochrome P450s by ethanol and isopentanol.
      C A Louis, S G Wood, V Kostrubsky, P R Sinclair and J F Sinclair
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 838-845;
  19. Singer, E A

    1. You have access
      Behavior of mesocortical dopamine terminals during single and repetitive stimulation: comparison with nigrostriatal neurons.
      E Agneter, I S Hoffmann, E A Singer and L X Cubeddu
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 470-476;
  20. Sleph, P G

    1. You have access
      The cardioprotective and electrophysiological effects of cromakalim are attenuated by meclofenamate through a cyclooxygenase-independent mechanism.
      G J Grover, A J D'Alonzo, P G Sleph, S Dzwonczyk, T A Hess and R B Darbenzio
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 536-540;
  21. Smyth, D D

    1. You have access
      Chlorotyrosine exerts renal effects and antagonizes renal and gastric responses to atrial natriuretic peptide.
      Q M Chen, D D Smyth, J K McKenzie, G B Glavin, J G Gu, J D Geiger and F S LaBella
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 709-716;
  22. St-Pierre, S

    1. You have access
      Binding profile of a selective calcitonin gene-related peptide (CGRP) receptor antagonist ligand, [125I-Tyr]hCGRP8-37, in rat brain and peripheral tissues.
      D Van Rossum, D P Ménard, A Fournier, S St-Pierre and R Quirion
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 846-853;
  23. Stein, R B

    1. You have access
      Cardiac electrophysiologic and antiarrhythmic actions of two long-acting spirobenzopyran piperidine class III agents, L-702,958 and L-706,000 [MK-499].
      J J Lynch, A A Wallace, R F Stupienski, E P Baskin, C M Beare, S D Appleby, J J Salata, N K Jurkiewicz, M C Sanguinetti and R B Stein
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 541-554;
  24. Stupienski, R F

    1. You have access
      Cardiac electrophysiologic and antiarrhythmic actions of two long-acting spirobenzopyran piperidine class III agents, L-702,958 and L-706,000 [MK-499].
      J J Lynch, A A Wallace, R F Stupienski, E P Baskin, C M Beare, S D Appleby, J J Salata, N K Jurkiewicz, M C Sanguinetti and R B Stein
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 541-554;
  25. Sugimachi, K

    1. You have access
      Chronic pharmacological activities of the novel anxiolytic beta-carboline abecarnil in rats.
      M Ozawa, K Sugimachi, Y Nakada-Kometani, T Akai and M Yamaguchi
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 457-462;
  26. Sukamoto, T

    1. You have access
      Sigma receptor-mediated effects of a new antiulcer agent, KB-5492, on experimental gastric mucosal lesions and gastric alkaline secretion in rats.
      H Hara, K Tanaka, Y Harada and T Sukamoto
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 799-805;
  27. Suzuki, Y

    1. You have access
      Nephrosis augments contractile response to adrenoceptor agonists by the decrease in release of endothelium-derived relaxing factor from the endothelial cells.
      M Ito, A Naruse, I Yamamoto, M Oguri, Y Suzuki, N Satake and S Shibata
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 589-595;

T

  1. Takada, K

    1. You have access
      Platelets-induced stimulation of endothelin-1 production and inhibition by phosphoramidon.
      T Umekawa, Y Matsumura, N Yoshimura, S Murata, K Takada, Y Tsukahara, M Takaoka and S Morimoto
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 860-866;
  2. Takaoka, M

    1. You have access
      The effects of NG-nitro-L-arginine, a nitric oxide synthase inhibitor, on norepinephrine overflow and antidiuresis induced by stimulation of renal nerves in anesthetized dogs.
      Y Egi, Y Matsumura, S Murata, T Umekawa, K Hisaki, M Takaoka and S Morimoto
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 529-535;
    2. You have access
      Platelets-induced stimulation of endothelin-1 production and inhibition by phosphoramidon.
      T Umekawa, Y Matsumura, N Yoshimura, S Murata, K Takada, Y Tsukahara, M Takaoka and S Morimoto
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 860-866;
  3. Tanaka, K

    1. You have access
      Sigma receptor-mediated effects of a new antiulcer agent, KB-5492, on experimental gastric mucosal lesions and gastric alkaline secretion in rats.
      H Hara, K Tanaka, Y Harada and T Sukamoto
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 799-805;
  4. Tencé, M

    1. You have access
      Muscarinic cholinergic agonists stimulate arachidonic acid release from mouse striatal neurons in primary culture.
      M Tencé, J Cordier, J Premont and J Glowinski
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 646-653;
  5. Thakore, E

    1. You have access
      Interaction of drug metabolites with the class I antiarrhythmic drug receptor on rat cardiac myocytes.
      R Sheldon, E Thakore, L Wilson and H Duff
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 477-481;
  6. Tousman, S A

    1. You have access
      Inhibitors of nitric oxide synthesis antagonize nitrous oxide antinociception in mice and rats.
      C E McDonald, M J Gagnon, E A Ellenberger, B L Hodges, J K Ream, S A Tousman and R M Quock
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 601-608;
  7. Toyomoto, T

    1. You have access
      Stimulation of Cl conductance by minoxidil sulfate and K conductance by minoxidil in eccrine clear cells.
      M Ohtsuyama, F Sato, T Toyomoto and K Sato
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 823-831;
  8. Tsukahara, Y

    1. You have access
      Platelets-induced stimulation of endothelin-1 production and inhibition by phosphoramidon.
      T Umekawa, Y Matsumura, N Yoshimura, S Murata, K Takada, Y Tsukahara, M Takaoka and S Morimoto
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 860-866;
  9. Tsutsumi, N

    1. You have access
      Novel rapid- and short-acting hypoglycemic agent, a calcium(2s)-2-benzyl-3-(cis-hexahydro-2-isoindolinylcarbonyl) propionate (KAD-1229) that acts on the sulfonylurea receptor: comparison of effects between KAD-1229 and gliclazide.
      H Ohnota, T Koizumi, N Tsutsumi, M Kobayashi, S Inoue and F Sato
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 489-495;
  10. Tsutsumi, R

    1. You have access
      Pharmacological profile of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo- 5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo.
      A Nishida, K Miyata, R Tsutsumi, H Yuki, S Akuzawa, A Kobayashi, T Kamato, H Ito, M Yamano and Y Katuyama
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 725-731;

U

  1. Ullrich, K J

    1. You have access
      Polysubstrates: substances that interact with renal contraluminal PAH, sulfate, and NMeN transport: sulfamoyl-, sulfonylurea-, thiazide- and benzeneamino-carboxylate (nicotinate) compounds.
      K J Ullrich, G Fritzsch, G Rumrich and C David
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 684-692;
  2. Umekawa, T

    1. You have access
      The effects of NG-nitro-L-arginine, a nitric oxide synthase inhibitor, on norepinephrine overflow and antidiuresis induced by stimulation of renal nerves in anesthetized dogs.
      Y Egi, Y Matsumura, S Murata, T Umekawa, K Hisaki, M Takaoka and S Morimoto
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 529-535;
    2. You have access
      Platelets-induced stimulation of endothelin-1 production and inhibition by phosphoramidon.
      T Umekawa, Y Matsumura, N Yoshimura, S Murata, K Takada, Y Tsukahara, M Takaoka and S Morimoto
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 860-866;

V

  1. Vale, W

    1. You have access
      Characterization of a novel and potent corticotropin-releasing factor antagonist in rats.
      F Menzaghi, R L Howard, S C Heinrichs, W Vale, J Rivier and G F Koob
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 564-572;
  2. Van Meel, J C

    1. You have access
      Different types of angiotensin II receptor antagonism induced by BIBS 222 in the rat portal vein and rabbit aorta; the influence of receptor reserve.
      J S Zhang, J C Van Meel, M Pfaffendorf and P A Van Zwieten
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 509-514;
  3. Van Rossum, D

    1. You have access
      Binding profile of a selective calcitonin gene-related peptide (CGRP) receptor antagonist ligand, [125I-Tyr]hCGRP8-37, in rat brain and peripheral tissues.
      D Van Rossum, D P Ménard, A Fournier, S St-Pierre and R Quirion
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 846-853;
  4. Van Zwieten, P A

    1. You have access
      Different types of angiotensin II receptor antagonism induced by BIBS 222 in the rat portal vein and rabbit aorta; the influence of receptor reserve.
      J S Zhang, J C Van Meel, M Pfaffendorf and P A Van Zwieten
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 509-514;
  5. Vilaine, J P

    1. You have access
      S 12340: a potent inhibitor of the oxidative modification of low-density lipoprotein in vitro and ex vivo in WHHL rabbits.
      C Breugnot, S Privat, C Guillonneau, G Regnier, F Bouzom, J P Vilaine and A Lenaers
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 515-520;
  6. Vis, P W

    1. You have access
      Characterization of the pharmacodynamics of several antiepileptic drugs in a direct cortical stimulation model of anticonvulsant effect in the rat.
      A Hoogerkamp, P W Vis, M Danhof and R A Voskuyl
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 521-528;
  7. Voit, M

    1. You have access
      Elevated susceptibility to 4-ipomeanol cytotoxicity in immature Clara cells of neonatal rabbits.
      C G Plopper, A J Weir, S J Nishio, A Chang, M Voit, R M Philpot and A R Buckpitt
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 867-880;
  8. Vonarx-Coinsman, V

    1. You have access
      Malondialdehyde dosimetry in laser-irradiated tissues sensitized by hematoporphyrin derivative.
      C Perret, M T Foultier, V Vonarx-Coinsman, O Quancard, A Combre and T Patrice
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 787-791;
  9. Voskuyl, R A

    1. You have access
      Characterization of the pharmacodynamics of several antiepileptic drugs in a direct cortical stimulation model of anticonvulsant effect in the rat.
      A Hoogerkamp, P W Vis, M Danhof and R A Voskuyl
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 521-528;

W

  1. Wallace, A A

    1. You have access
      Cardiac electrophysiologic and antiarrhythmic actions of two long-acting spirobenzopyran piperidine class III agents, L-702,958 and L-706,000 [MK-499].
      J J Lynch, A A Wallace, R F Stupienski, E P Baskin, C M Beare, S D Appleby, J J Salata, N K Jurkiewicz, M C Sanguinetti and R B Stein
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 541-554;
  2. Wang, Y X

    1. You have access
      Effects of adrenalectomy and chemical sympathectomy on pressor and tachycardic responses to diphenyleneiodonium.
      Y X Wang and C C Pang
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 463-469;
  3. Warnery, A

    1. You have access
      High lipophilicity decreases drug transport across intestinal epithelial cells.
      P Wils, A Warnery, V Phung-Ba, S Legrain and D Scherman
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 654-658;
  4. Waters, S M

    1. You have access
      Acute administration of neuroleptics decreases neurotensin metabolism on intact, regional rat brain slices.
      C S Konkoy, S M Waters and T P Davis
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 555-563;
  5. Watts, S W

    1. You have access
      Mechanism of ergonovine-induced contraction in the mesenteric artery from deoxycorticosterone acetate-salt hypertensive rat.
      S W Watts and R C Webb
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 617-625;
  6. Waxman, D J

    1. You have access
      Cimetidine prevents alcoholic hepatic injury in the intragastric feeding rat model.
      A A Nanji, S Zhao, S Khwaja, S M Sadrzadeh and D J Waxman
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 832-837;
  7. Webb, R C

    1. You have access
      Mechanism of ergonovine-induced contraction in the mesenteric artery from deoxycorticosterone acetate-salt hypertensive rat.
      S W Watts and R C Webb
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 617-625;
  8. Weir, A J

    1. You have access
      Elevated susceptibility to 4-ipomeanol cytotoxicity in immature Clara cells of neonatal rabbits.
      C G Plopper, A J Weir, S J Nishio, A Chang, M Voit, R M Philpot and A R Buckpitt
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 867-880;
  9. Williams, C L

    1. You have access
      SNF9007: a novel analgesic that acts simultaneously at delta 1, delta 2 and mu opioid receptors.
      C L Williams, G C Rosenfeld, N Dafny, S N Fang, V J Hruby, G Bowden, C A Cullinan and T F Burks
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 750-755;
  10. Wils, P

    1. You have access
      High lipophilicity decreases drug transport across intestinal epithelial cells.
      P Wils, A Warnery, V Phung-Ba, S Legrain and D Scherman
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 654-658;
  11. Wilson, L

    1. You have access
      Interaction of drug metabolites with the class I antiarrhythmic drug receptor on rat cardiac myocytes.
      R Sheldon, E Thakore, L Wilson and H Duff
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 477-481;
  12. Wood, S G

    1. You have access
      Synergistic increases in rat hepatic cytochrome P450s by ethanol and isopentanol.
      C A Louis, S G Wood, V Kostrubsky, P R Sinclair and J F Sinclair
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 838-845;

X

  1. Xue, Z

    1. You have access
      Withdrawal from continuous or intermittent cocaine administration: changes in D2 receptor function.
      G R King, E H Ellinwood, C Silvia, C M Joyner, Z Xue, M G Caron and T H Lee
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 743-749;

Y

  1. Yamaguchi, M

    1. You have access
      Chronic pharmacological activities of the novel anxiolytic beta-carboline abecarnil in rats.
      M Ozawa, K Sugimachi, Y Nakada-Kometani, T Akai and M Yamaguchi
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 457-462;
  2. Yamamoto, I

    1. You have access
      Nephrosis augments contractile response to adrenoceptor agonists by the decrease in release of endothelium-derived relaxing factor from the endothelial cells.
      M Ito, A Naruse, I Yamamoto, M Oguri, Y Suzuki, N Satake and S Shibata
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 589-595;
  3. Yamano, M

    1. You have access
      Pharmacological profile of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo- 5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo.
      A Nishida, K Miyata, R Tsutsumi, H Yuki, S Akuzawa, A Kobayashi, T Kamato, H Ito, M Yamano and Y Katuyama
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 725-731;
  4. Yang, H T

    1. You have access
      Dissociation of the positive inotropic effect of methoxamine from the hydrolysis of phosphoinositide in rabbit ventricular myocardium: a comparison with the effects of phenylephrine and the subtype of the alpha-1 adrenoceptor involved.
      H T Yang and M Endoh
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 732-742;
  5. Yoshimura, N

    1. You have access
      Platelets-induced stimulation of endothelin-1 production and inhibition by phosphoramidon.
      T Umekawa, Y Matsumura, N Yoshimura, S Murata, K Takada, Y Tsukahara, M Takaoka and S Morimoto
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 860-866;
  6. Yuan, J

    1. You have access
      Dexfenfluramine and serotonin neurotoxicity: further preclinical evidence that clinical caution is indicated.
      U McCann, G Hatzidimitriou, A Ridenour, C Fischer, J Yuan, J Katz and G Ricaurte
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 792-798;
  7. Yuki, H

    1. You have access
      Pharmacological profile of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo- 5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo.
      A Nishida, K Miyata, R Tsutsumi, H Yuki, S Akuzawa, A Kobayashi, T Kamato, H Ito, M Yamano and Y Katuyama
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 725-731;

Z

  1. Zhang, J S

    1. You have access
      Different types of angiotensin II receptor antagonism induced by BIBS 222 in the rat portal vein and rabbit aorta; the influence of receptor reserve.
      J S Zhang, J C Van Meel, M Pfaffendorf and P A Van Zwieten
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 509-514;
  2. Zhao, S

    1. You have access
      Cimetidine prevents alcoholic hepatic injury in the intragastric feeding rat model.
      A A Nanji, S Zhao, S Khwaja, S M Sadrzadeh and D J Waxman
      Journal of Pharmacology and Experimental Therapeutics May 1994, 269 (2) 832-837;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 269, Issue 2
1 May 1994
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics